Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Eventide
company
About
Eventide is an asset management company that provides investment services for individuals, financial advisors, and institutions.
- 51 - 100
Highlights
Details
- Industries
- Asset Management,Finance,Financial Services,Wealth Management
- Founded date
- Jan 1, 2008
- Number Of Employee
- 51 - 100
- Operating Status
- Active
- Investor Type
- Venture Capital
Eventide Asset Management, LLC is a Boston-based investment adviser practicing "investing that makes the world rejoice®." Founded in 2008, Eventide's vision is to serve individuals, financial advisors, and institutions by providing high-performance investments that we believe create compelling value for the global common good.
Investments
Number of Investments
Number of Lead Investments
5
1
Eventide has made 5 investments. Their most recent investment was on
Jan 25, 2022, when Metagenomi raised $175M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jan 25, 2022
Metagenomi
|
Series B | $175M | Artificial Intelligence | — |
|
Dec 7, 2021
Freenome
|
Series D | $300M | Biotechnology | — |
|
Oct 1, 2021
Roivant Sciences
|
Post-IPO Equity | $200M | Biopharma | — |
|
Nov 9, 2020
Prometheus Biosciences
|
Private Equity（PE） | $130M | Biotechnology | Yes |
|
Mar 18, 2019
Karuna Therapeutics
|
Series B | $68M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
